Bleomycin
Top View
- Artesunate Enhances the Cytotoxicity of 5-Aminolevulinic Acid-Based Sonodynamic Therapy Against Mouse Mammary Tumor Cells in Vitro
- Preclinical Studies of Photodynamic Therapy and Photochemical Internalization in Bladder Cancer
- Kreftfondet Ved St
- Safe Handling of Hazardous Chemotherapy Drugs in Limited-Resource Settings
- High Dose Melphalan, BCNU and Etoposide with Autologous Bone Marrow Transplantation for Hodgkin's Disease
- Package Leaflet: Information for the Patient Bleomycin 15000 IU Powder
- PREMEDICATION REGIMENS TAXANES Paclitaxel Dexamethasone 20 Mg PO at 12 and 6 Hours Prior to Paclitaxel AND/OR 20 Mg IV As a Single Dose 30 Minutes Prior to Paclitaxel
- Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents
- BC Cancer Protocol Summary for Curative Therapy for Germ Cell Cancer Using Bleomycin, Etoposide and Cisplatin
- DBL Bleomycin Sulfate for Injection Is a White to Cream Coloured Lyophilised Powder Or Plug
- Biweekly THP-COPBLM (Pirarubicin, Cyclophosphamide, Vincristine
- The Immunomodulatory Effects of Arsenic Trioxide in Autoimmunity and Alloreactivity Yishan Ye
- 5-Aminolevulinic Acid Enhances Ultrasound-Mediated Antitumor Activity Via Mitochondrial Oxidative Damage in Breast Cancer
- Etoposide in Combination with Cisplatin and Bleomycin
- Arsenic Trioxide Inhibits Transforming Growth Factor-Β1-Induced Fibroblast
- Toxicities Associated with Bleomycin Clinical
- Inhibition of Malignant Glial Cell Growth by Estramustine, an Estrogen
- Bleomycin Etoposide Cisplatin 3 Day (BEP3 Adjuvant)